FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

MS Klevesath

Research Profile

Chemicals & Drugs

Disorders

Anatomy

Endothelium, Vascular

Concepts & Ideas

Procedures

Hemofiltration

Co-author Network

Publications

TOP 3
Peter Quehenberger; Angelika Bierhaus; Peter Fasching; C Muellner; MS Klevesath; M Hong; G Stier; M Sattler; E Schleicher; Wolfgang Speiser; Peter P Nawroth
Endothelin 1 transcription is controlled by nuclear factor-kappaB in AGE-stimulated cultured endothelial cells.
A Clemens; MS Klevesath; Michael Hofmann; F Raulf; M Henkels; J Amiral; M J Seibel; J Zimmermann; Reinhard Ziegler; P Wahl; Peter P Nawroth
Octreotide (somatostatin analog) treatment reduces endothelial cell dysfunction in patients with diabetes mellitus.
H Böhrer; U Mieck; R Hofmann; MS Klevesath; Peter P Nawroth; Eike Martin
Minimal leptin elimination into ultrafiltrate during continuous venovenous haemofiltration in patients with sepsis.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of MS Klevesath (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2000: Peter Quehenberger; Angelika Bierhaus; Peter Fasching; C Muellner; MS Klevesath; M Hong; G Stier; M Sattler; E Schleicher; Wolfgang Speiser; Peter P Nawroth
Endothelin 1 transcription is controlled by nuclear factor-kappaB in AGE-stimulated cultured endothelial cells.
Diabetes 2000;49(9):1561-70.
1999: A Clemens; MS Klevesath; Michael Hofmann; F Raulf; M Henkels; J Amiral; M J Seibel; J Zimmermann; Reinhard Ziegler; P Wahl; Peter P Nawroth
Octreotide (somatostatin analog) treatment reduces endothelial cell dysfunction in patients with diabetes mellitus.
Metabolism: clinical and experimental 1999;48(10):1236-40.
1999: H Böhrer; U Mieck; R Hofmann; MS Klevesath; Peter P Nawroth; Eike Martin
Minimal leptin elimination into ultrafiltrate during continuous venovenous haemofiltration in patients with sepsis.
European journal of anaesthesiology 1999;16(8):539-42.
1999: A K Borm; MS Klevesath; V Borcea; Christian Kasperk; M J Seibel; P Wahl; Reinhard Ziegler; P P Naworth
The effect of pramlintide (amylin analogue) treatment on bone metabolism and bone density in patients with type 1 diabetes mellitus.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme 1999;31(8):472-5.
1999: V Borcea; Jaffar Nourooz-Zadeh; S P Wolff; MS Klevesath; Michael Hofmann; H Urich; P Wahl; Reinhard Ziegler; Hans Tritschler; Barry Halliwell; Peter P Nawroth
alpha-Lipoic acid decreases oxidative stress even in diabetic patients with poor glycemic control and albuminuria.
Free radical biology & medicine 1999;26(11-12):1495-500.
1998: Michael Hofmann; Stephan Schiekofer; M Kanitz; MS Klevesath; Martina Joswig; V Lee; Michael Morcos; Hans Tritschler; Reinhard Ziegler; P Wahl; Angelika Bierhaus; Peter P Nawroth
Insufficient glycemic control increases nuclear factor-kappa B binding activity in peripheral blood mononuclear cells isolated from patients with type 1 diabetes.
Diabetes care 1998;21(8):1310-6.
1998: Youming Zhang; H Weiler-Guettler; J Chen; Olaf G Wilhelm; Y Deng; F Qiu; K Nakagawa; MS Klevesath; S Wilhelm; H Böhrer; M Nakagawa; Henner Graeff; Eike Martin; David M Stern; R D Rosenberg; Reinhard Ziegler; Peter P Nawroth
Thrombomodulin modulates growth of tumor cells independent of its anticoagulant activity.
The Journal of clinical investigation 1998;101(7):1301-9.